cas 2641216-67-1|| where to buy 19-chloro-22-[2,5-dimethyl-4-(prop-2-enoyl)piperazin-1-yl]-13,16-difluoro-3-(propan-2-yl)-8,11-dioxa-1,4,23,26-tetraazapentacyclo[16.6.2.0²,⁷.0¹²,¹⁷.0²¹,²⁵]hexacosa-2(7),3,5,12,14,16,18,20,22,25-decaen-24-one

Produktname:19-chloro-22-[2,5-dimethyl-4-(prop-2-enoyl)piperazin-1-yl]-13,16-difluoro-3-(propan-2-yl)-8,11-dioxa-1,4,23,26-tetraazapentacyclo[16.6.2.0²,⁷.0¹²,¹⁷.0²¹,²⁵]hexacosa-2(7),3,5,12,14,16,18,20,22,25-decaen-24-one

IUPAC Name:19-chloro-22-[2,5-dimethyl-4-(prop-2-enoyl)piperazin-1-yl]-13,16-difluoro-3-(propan-2-yl)-8,11-dioxa-1,4,23,26-tetraazapentacyclo[16.6.2.0²,⁷.0¹²,¹⁷.0²¹,²⁵]hexacosa-2(7),3,5,12,14,16,18,20,22,25-decaen-24-one

: CAS：2641216-67-1; Molekulare Formel：C32H31ClF2N6O4; Reinheit：95%+

: Katalognummer：CM1078967; Molekulargewicht：637.08

Packungseinheit	Verfügbarer Vorrat	Preis($)	Menge

Anfrage: sales@chemenu.com

Nur für den Einsatz in Forschung und Entwicklung..

Anfrage-Formular

Chemische Bezeichnung

CAS-Nummer

Menge*

Erforderliche Spezifikationen*
(Gehalt %, Materialqualität etc.)

Name des Ansprechpartners*

E-Mail des Ansprechpartners*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 2641216-67-1 regularly via the above email.

Zusätzliche Hinweise

Verification code*

refresh

Produkt-Details

: CAS-Nr.:2641216-67-1; Molekulare Formel:C32H31ClF2N6O4; Schmelzpunkt:-; SMILES-Code:CC1CN(C(CN1C(=O)C=C)C)C2=NC(=O)N3C4=C(C=CN=C4C(C)C)OCCOC5=C(C=CC(=C5C6=C(C=C2C3=N6)Cl)F)F; Dichte:

: Katalognummer:CM1078967; Molekulargewicht:637.08; Siedepunkt:; Mdl-Nr.:; Lagerung:

Category Infos

: Piperazines; Piperazine is an organic compound consisting of a six-membered ring containing two nitrogen atoms in opposite positions in the ring. The chemical formula of piperazine is C4H10N2, and it is an important pharmaceutical intermediate. Pyrimidines and piperazines are known to be the backbone of many bulk compounds and important core structures for approved drugs; studies have shown that combining a pyridine ring with a piperazine moiety within a single structural framework enhances biological activity.